Stock Price
3.57
Daily Change
0.24 7.21%
Monthly
-9.16%
Yearly
75.00%
Q2 Forecast
5.00

Acasti Pharma reported $75K in Gross Profit on Sales for its fiscal quarter ending in March of 2021.





Gross Profit On Sales Change Date
Acasti Pharma USD 75K 30K Mar/2021
Addus HomeCare USD 123.6M 6.89M Dec/2025
Amarin USD 23.17M 961K Dec/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Option Care Health USD 282.9M 10M Dec/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Tilray USD 57.47M 10.16M Jun/2025